BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38068409)

  • 1. Upregulation of Platelet-Activating Factor Receptor Expression and Lyso-Platelet-Activating Factor Isoforms in Human Nasal Polyp Tissues.
    Roca-Ferrer J; Pérez-González M; Alobid I; Tubita V; Fuentes M; Bantulà M; Muñoz-Cano R; Valero A; Izquierdo I; Mullol J
    J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor in human normal tears.
    Okumura N; Kojima K; Hashida M; Koura Y; Fukushima A; Ueno H
    Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
    Mullol J; Laidlaw TM; Bachert C; Mannent LP; Canonica GW; Han JK; Maspero JF; Picado C; Daizadeh N; Ortiz B; Li Y; Ruddy M; Laws E; Amin N
    Allergy; 2022 Apr; 77(4):1231-1244. PubMed ID: 34459002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and role of IL-18 in chronic rhinosinusitis].
    Liu RW; Du JT; Liu YF; Liu SX
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 32(7):497-501. PubMed ID: 29798077
    [No Abstract]   [Full Text] [Related]  

  • 5. Decrease of ciliary beat frequency by platelet activating factor: protective effect of ketotifen.
    Kahhak L; Roche A; Dubray C; Arnoux C; Benveniste J
    Inflamm Res; 1996 May; 45(5):234-8. PubMed ID: 8737746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis.
    Okumura N; Fukushima A; Igarashi A; Sumi T; Yamagishi T; Ueno H
    J Ocul Pharmacol Ther; 2006 Oct; 22(5):347-52. PubMed ID: 17076629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Association between Transglutaminase 1 and Tissue Eosinophil Infiltration Leading to Nasal Polyp Formation and/or Maintenance with Fibrin Polymerization in Chronic Rhinosinusitis with Nasal Polyps.
    Sonoyama T; Ishino T; Takemoto K; Yamato K; Oda T; Nishida M; Horibe Y; Chikuie N; Kono T; Taruya T; Hamamoto T; Ueda T; Takeno S
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypoxic stimulation leads to the changes of inflammatory factors in mucosal epithelial cells of nasal polyps].
    Xiu Q; Gao YY; Zhu DD
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Mar; 56(3):263-272. PubMed ID: 33730810
    [No Abstract]   [Full Text] [Related]  

  • 9. The nasal microbiome in patients suffering from non-steroidal anti-inflammatory drugs-exacerbated respiratory disease in absence of corticosteroids.
    Bartosik TJ; Campion NJ; Freisl K; Liu DT; Gangl K; Stanek V; Tu A; Pjevac P; Hausmann B; Eckl-Dorna J; Schneider S
    Front Immunol; 2023; 14():1112345. PubMed ID: 37122714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of IL-17 and syndecan-1 in nasal polyps and their correlation with nasal polyps.
    Gong GQ; Ren FF; Wang YJ; Wan L; Chen S; Yuan J; Yang CM; Liu BH; Kong WJ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):412-418. PubMed ID: 28585128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma.
    Simon HU; Tsao PW; Siminovitch KA; Mills GB; Blaser K
    J Immunol; 1994 Jul; 153(1):364-77. PubMed ID: 8207248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics.
    Busse WW; Pavord ID; Siddiqui S; Khan AH; Praestgaard A; Nash S; Jacob-Nara JA; Rowe PJ; Deniz Y
    J Asthma Allergy; 2023; 16():411-419. PubMed ID: 37096015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can nasal acetylsalicylic acid challenge predict the severity of non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (N-ERD)?
.
    Förster-Ruhrmann U; Tietz AK; Kim J; Liebers U; Szczepek AJ; Olze H
    Allergol Select; 2020; 4():135-143. PubMed ID: 33393939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi.
    Gazos-Lopes F; Oliveira MM; Hoelz LV; Vieira DP; Marques AF; Nakayasu ES; Gomes MT; Salloum NG; Pascutti PG; Souto-Padrón T; Monteiro RQ; Lopes AH; Almeida IC
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3077. PubMed ID: 25101628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the metabolism of lyso-platelet activating factor (lyso-PAF) in human paranasal sinus mucosa. The cultured ciliated epithelium can convert lyso-PAF to PAF.
    Inoue H; Ganbo T; Hisamatsu K; Ishida H
    Life Sci; 1993; 52(21):PL227-32. PubMed ID: 8502110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pleiomorphism of the cytokine profile in nasal polyp tissue depending on the phenotype of chronic rhinosinusitis with nasal polyps].
    Savlevich EL; Zurochka AV; Kurbacheva OM; Egorov VI; Shilovskiy IP; Mitrofanova ES; Lyubimova EV
    Vestn Otorinolaringol; 2023; 88(1):50-56. PubMed ID: 36867144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps.
    Pace E; Scafidi V; Di Bona D; Siena L; Chiappara G; Ferraro M; La Grutta S; Gallina S; Speciale R; Ballacchino A; Bachert C; Bousquet J; Gjomarkaj M
    Allergy; 2012 Jul; 67(7):878-86. PubMed ID: 22583192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab in patients with NSAIDs-exacerbated respiratory disease.
    Forster-Ruhrmann U; Stergioudi D; Pierchalla G; Fluhr JW; Bergmann KC; Olze H
    Rhinology; 2020 Jun; 58(3):226-232. PubMed ID: 32077449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps.
    Wei Y; Xia W; Ye X; Fan Y; Shi J; Wen W; Yang P; Li H;
    J Allergy Clin Immunol; 2014 Feb; 133(2):420-8. PubMed ID: 24342548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.